1
Vasculogenic Mimicry in Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:March 5, 2020Not yet recruiting
Carcinoma, Transitional Cell: 665 Clinical Trials, Page 1 of 67
Hide Studies Not Open or Pending
2
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
Condition(s):Urothelial Carcinoma; Bladder CancerLast Updated:March 20, 2020Recruiting
3
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:August 25, 2020Recruiting
4
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Condition(s):Carcinoma, Transitional CellLast Updated:August 31, 2020Active, not recruiting
5
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:August 19, 2015Withdrawn
6
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
Condition(s):Urothelial CarcinomaLast Updated:June 16, 2020Recruiting
7
DNA Methylation and Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:June 22, 2011Unknown status
8
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Condition(s):Carcinoma, Transitional CellLast Updated:February 13, 2017Not yet recruiting
9
DNA Methylation and Arsenic-associated Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:May 27, 2011Unknown status
10
A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma
Condition(s):Metastatic Urothelial CarcinomaLast Updated:August 24, 2020Recruiting